Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Tolero Pharmaceuticals Inc.
DescriptionSmall molecule inhibitor of the janus kinase-2 (JAK-2) and bone morphogenetic protein (BMP) signaling pathways
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAnemia
Indication DetailsTreat anemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today